Clostridial Diseases of Horses: A Review
Overview
Affiliations
The clostridial diseases of horses can be divided into three major groups: enteric/enterotoxic, histotoxic, and neurotoxic. The main enteric/enterotoxic diseases include those produced by type C and , both of which are characterized by enterocolitis. The main histotoxic diseases are gas gangrene, Tyzzer disease, and infectious necrotic hepatitis. Gas gangrene is produced by one or more of the following microorganisms: type A, , and type A, and it is characterized by necrotizing cellulitis and/or myositis. Tyzzer disease is produced by and is mainly characterized by multifocal necrotizing hepatitis. Infectious necrotic hepatitis is produced by type B and is characterized by focal necrotizing hepatitis. The main neurotoxic clostridial diseases are tetanus and botulism, which are produced by and , respectively. Tetanus is characterized by spastic paralysis and botulism by flaccid paralysis. Neither disease present with specific gross or microscopic lesions. The pathogenesis of clostridial diseases involves the production of toxins. Confirming a diagnosis of some of the clostridial diseases of horses is sometimes difficult, mainly because some agents can be present in tissues of normal animals. This paper reviews the main clostridial diseases of horses.
Severe subcutaneous infection with Clostridium septicum in a herd of native Icelandic horses.
Oddsdottir C, Sigurdardottir O, Fridriksdottir V, Svansson V, Bragason B, Bjornsdottir S Acta Vet Scand. 2025; 67(1):8.
PMID: 39910631 PMC: 11800538. DOI: 10.1186/s13028-025-00792-y.
Jurisic L, Auerswald H, Marcacci M, Di Giallonardo F, Coetzee L, Curini V J Virol. 2025; 99(2):e0214424.
PMID: 39853116 PMC: 11852760. DOI: 10.1128/jvi.02144-24.
A Review of Epithelial Ion Transporters and Their Roles in Equine Infectious Colitis.
Haywood L, Sheahan B Vet Sci. 2024; 11(10).
PMID: 39453072 PMC: 11512231. DOI: 10.3390/vetsci11100480.
Kabir A, Lamichhane B, Habib T, Adams A, El-Sheikh Ali H, Slovis N Antibiotics (Basel). 2024; 13(8).
PMID: 39200013 PMC: 11350719. DOI: 10.3390/antibiotics13080713.
Filigenzi M J Vet Diagn Invest. 2024; 36(6):777-789.
PMID: 39175303 PMC: 11529146. DOI: 10.1177/10406387241270071.